Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2025 (IFRS)
SANTEN PHARMA, Apr-Dec (Cumulative 3Q) Net Income Decreases by 21%, Oct-Dec Net Income Decreases by 9%
Santen Announces Cancellation of Treasury Shares
Santen Announces Completion of Share Buyback
Summary of Consolidated Financial Results for the Six Months Ended September 30, 2025 (IFRS)
SANTEN PHARMA, First Half Net Income Decreases by 26%
Santen Announces Status of Share Buyback
Notice on the Completion of Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration Plan
Santen Announces Status of Share Buyback
Notice on the Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration Plan
(Cancellation of Disclosure) Notice of suspension of the Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration
Notice on the Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration Plan
Santen Announces Status of Share Buyback
Summary of Consolidated Financial Results for the Three Months Ended June 30, 2025 (IFRS)
SANTEN PHARMA, Apr-Jun (1Q) Net Income Decreases by 45%
Santen Announces Status of Share Buyback
Corporate Governance Report
Santen Announces Status of Share Buyback
Santen Announces Status of Share Buyback
Summary of Consolidated Financial Results for the Year Ended March 31, 2025 (IFRS)